Evaluation of the difference between enophthalmos of both eyes in the patients who are treated unilaterally with ophthalmic solution for glaucoma

Evaluation of the difference between enophthalmos of both eyes in the patients who are treated unilaterally with ophthalmic solution for glaucoma - Evaluation of the difference between enophthalmos of both eyes in the patients with glaucoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018590

Enrollment

Registered

2015-08-07

Start date

2015-08-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are already treated unilaterally with prostaglandin ophthalmic solution

Exclusion criteria

Exclusion criteria: Patients who can not undergo MRI examination

Design outcomes

Primary

Measure	Time frame
The difference between enophthalmos of both eyes	—

Secondary

Measure	Time frame
The difference between volumes of orbital fatty tissue of both eyes	—

Countries

Japan

Contacts

Public ContactTomoaki Higashiyama

Shiga University of Medical Science Department of Ophthalmology

higashi@belle.shiga-med.ac.jp0775482276

Outcome results